Journal: ImmunoHorizons
Article Title: Direct contact with natural killer cells reprograms monocyte-derived dendritic cells into a tolerogenic phenotype
doi: 10.1093/immhor/vlag007
Figure Lengend Snippet: IL-10 signaling is critical for the tolerogenic effect from the NK-programmed DC. (A) Study design of knocking-out transcription factors and evaluating the resultant DC tolerance effects. (B) IL-10, TNF-α, and IL-6 cytokine production was assayed from LPS-stimulated MoDCs after CRISPR-Cas9 editing. CRISPR-KO MoDC effect on T-cell activation in MLR evaluated by flow cytometry showing (C) CD25 expression on CD4 T cells and CD8 T cells ( n = 3 donors) and (D) evaluated MLR secreted cytokines IL-10, TNF-α, and IFN-γ ( n = 3 donors). Means ± SEM are shown, and statistical analysis is determined by one-way ANOVA Fisher least significant difference test compared to the scramble sgRNA control. * P < .05, ** P < .01, *** P < .001, **** P < .0001. (E) Study design of neutralizing IL-10 during the depletion of MoDCs by anti-DCIR–induced ADCC effect. (F) Cell count and (G, H) MFI of DC co-stimulatory/maturation markers (CD40 and CD44) on surviving CD14 + CD11c + MoDCs in the ADCC assay induced by anti-DCIR antibody in combination with or without anti-IL-10 neutralizing antibody ( n = 3 donors). (I) IL-10R expression and (J) cell viability of the MoDCs differentiated by GM-CSF and IL-4 treatment and matured by CpG and CD40L stimulation, along with indoximod, an IDO1 inhibitor ( n = 4 donors). (K) Schematic summary of the tolerogenesis of DCs from the NK engagement induced by DC-targeting antibody (eg anti-DCIR).
Article Snippet: For the MLR experiment in , PBMCs were isolated from fresh human whole blood and treated with 40 ng/mL human IL-4 and 100 ng/mL human GM-CSF for 3 days to induce MoDC differentiation, followed by CpG ODN2006 (Invivogen, Cat# tlrl-2006) and CD40L (PeproTech, Cat#310-02) to promote MoDC maturation in addition to anti-DCIR antibody to induce antibody-dependent cellular cytotoxicity (ADCC) for 2 to 3 days.
Techniques: CRISPR, Activation Assay, Flow Cytometry, Expressing, Control, Cell Characterization, ADCC Assay